Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib

doi:10.4254/wjh.v15.i11.1188

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2425)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

WORD

HTML

1215

Figures (1-1)

164

Tables (1-1)

150

Sum=1612

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

127

Download

272

Sum=399

Publishing Process of This Article

Item

Count

Browse

118

Download

194

Sum=312

Nov 27, 2023 (publication date) through Jun 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Nov 27, 2023; 15(11): 1188-1195
Published online Nov 27, 2023. doi: 10.4254/wjh.v15.i11.1188

Open in New Tab Full Size Figure Download Figure

Figure 1 Benefits and risks of ruxolitinib use in terms of opportunistic infections in myeloproliferative neoplasms. MPNs: Myeloproliferative neoplasms; RUX: Ruxolitinib; HBVr: Hepatitis B virus reactivation; NK cells: Natural killer cells.

Citation: Adesola AA, Cozma MA, Chen YF, Srichawla BS, Găman MA. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib. World J Hepatol 2023; 15(11): 1188-1195
URL: https://www.wjgnet.com/1948-5182/full/v15/i11/1188.htm
DOI: https://dx.doi.org/10.4254/wjh.v15.i11.1188